Please assess the completion status of the following clinical trial:

Trial Title: A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female patients at the age of 18 years or older who have diagnosis of chronic, posterior uveitis, intermediate uveitis or panuveitis~Exclusion Criteria:~* Patients receiving specific medication/interventions as specified per protocol~* Pregnant or nursing patients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PP-001 (Type: EXPERIMENTAL): Single intravitreal injection of 3 up to 4 doses of PP-001

Based on this trial design, predict the completion outcome and termination type (if applicable).